InnovaPrep is proud to announce an innovative breakthrough in isolating and concentrating exosomes and small extracellular vesicles (EVs)—key targets in disease diagnostics and personalized medicine. Exosomes and EVs, tiny vesicles released from host cells, carry critical biomolecules such as proteins and nucleic acids, enabling intercellular communication. Their potential as biomarkers has made them invaluable for early disease detection and personalized therapeutic approaches.
A New Standard for EV Isolation
Traditional methods for isolating EVs, such as ultracentrifugation, are labor-intensive, time-consuming, and complex. InnovaPrep's Concentrating Pipette (CP Select™), powered by our patented Wet Foam Elution™ (WFE) technology, offers a transformative alternative. This benchtop concentrator delivers highly concentrated, intact, and biologically active targets from dilute and complex samples with unparalleled efficiency, speed, and versatility, streamlining sample preparation workflows for both clinical and research applications.
“InnovaPrep’s technology bridges the gap between traditional and next-generation workflows,” said Dave Alburty, CEO of InnovaPrep. “The CP Select’s ability to collect and concentrate EVs from biofluids into small, highly concentrated samples opens new doors for improved biomarker detection, facilitating a wide array of downstream analytical procedures. This includes compatibility with protein assays, nucleic acid assays, and microscopic analysis—enhancing its utility in both research and diagnostics.”
Advancing Disease Diagnostics and Precision Medicine
Ongoing efforts at InnovaPrep are focused on optimizing workflows for EV isolation from biofluids such as urine, blood, plasma, and cerebrospinal fluid (CSF). By simplifying and accelerating sample preparation, the CP Select is poised to become an indispensable tool in clinical diagnostics and biomarker research.
In collaboration with developers of cutting-edge detection technologies, InnovaPrep is pushing the boundaries of disease-related biomarker analysis. By integrating the CP Select™ with these advanced tools, researchers and clinicians alike can take a significant leap forward in exosome isolation, improving workflows, reducing processing times, and accelerating discoveries.
Whether advancing biomarker research or enhancing clinical diagnostics, InnovaPrep's Wet Foam Elution™ technology is set to redefine the future of EV isolation.
